{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:45:35Z","timestamp":1780339535765,"version":"3.54.1"},"reference-count":58,"publisher":"Japan Society of Smooth Muscle Research","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Smooth Muscle Res","J. Smooth Muscle Res."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1540\/jsmr.61.82","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T22:08:21Z","timestamp":1756764501000},"page":"82-92","source":"Crossref","is-referenced-by-count":5,"title":["Growth factors involved in vascular remodeling in pulmonary arterial          hypertension"],"prefix":"10.1540","volume":"61","author":[{"given":"Aya","family":"Yamamura","sequence":"first","affiliation":[{"name":"Department of Physiology, Aichi Medical University, 1-1            Yazakokarimata, Nagakute, Aichi 480-1195, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"435","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hassoun,                PM,                Mouthon,              L,                Barber\u00e0,              JA,                Eddahibi,              S,                Flores,              SC,                Grimminger,                F, et al.          Inflammation, growth factors, and pulmonary vascular            remodeling. J Am Coll Cardiol. 2009;            54(1          Suppl): S10\u20139.","DOI":"10.1016\/j.jacc.2009.04.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Morrell,                NW,                Adnot,              S,                Archer,              SL,                Dupuis,              J,                Lloyd Jones,                P,                MacLean,              MR, et al.          Cellular and molecular basis of pulmonary arterial            hypertension. J Am Coll Cardiol. 2009;            54(1          Suppl): S20\u201331.","DOI":"10.1016\/j.jacc.2009.04.018"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kuhr,              FK,                Smith,              KA,                Song,              MY,                Levitan,              I,                Yuan,              JX. New            mechanisms of pulmonary arterial hypertension: role of Ca<sup>2+<\/sup>            signaling. Am J Physiol Heart Circ Physiol.            2012; 302(8):            H1546\u201362.","DOI":"10.1152\/ajpheart.00944.2011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fernandez,                RA,                Wan,              J,                Song,              S,                Smith,              KA,                Gu,              Y,                Tauseef,              M, et al.          Upregulated expression of STIM2, TRPC6, and Orai2 contributes to the            transition of pulmonary arterial smooth muscle cells from a contractile to proliferative            phenotype. Am J Physiol Cell Physiol.          2015; 308(8):            C581\u201393.","DOI":"10.1152\/ajpcell.00202.2014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. McLaughlin,                VV,                Shah,              SJ,                Souza,              R,                Humbert,              M. Management            of pulmonary arterial\u00a0hypertension. J Am Coll Cardiol.            2015; 65(18):            1976\u201397.","DOI":"10.1016\/j.jacc.2015.03.540"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fukuda,              K,                Date,              H,                Doi,              S,                Fukumoto,              Y,                Fukushima,                N,                Hatano,              M, et al.          Japanese Circulation Society and the Japanese Pulmonary Circulation and            Pulmonary Hypertension Society Joint Working Group.          Guidelines for the treatment of pulmonary hypertension (JCS 2017\/JPCPHS            2017). Circ J. 2019;            83(4): 842\u2013945.","DOI":"10.1253\/circj.CJ-66-0158"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hassoun,                PM. Pulmonary            arterial hypertension. N Engl J Med. 2021;            385(25): 2361\u201376.","DOI":"10.1056\/NEJMra2000348"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Frumkin,                LR. The            pharmacological treatment of pulmonary arterial hypertension.            Pharmacol Rev. 2012;          64(3): 583\u2013620.","DOI":"10.1124\/pr.111.005587"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Montani,              D,                Chaumais,                MC,                Guignabert,                C,                G\u00fcnther,              S,                Girerd,              B,                Ja\u00efs,              X, et al.          Targeted therapies in pulmonary arterial hypertension.            Pharmacol Ther. 2014;            141(2): 172\u201391.","DOI":"10.1016\/j.pharmthera.2013.10.002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tu,                L,                Guignabert,                C. Emerging            molecular targets for anti-proliferative strategies in pulmonary arterial            hypertension. Handb Exp Pharmacol. 2013;            218: 409\u201336.","DOI":"10.1007\/978-3-642-38664-0_17"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cs\u00f3sza,              G,                Karl\u00f3cai,              K,                Losonczy,              G,                M\u00fcller,              V,                L\u00e1z\u00e1r,              Z. Growth            factors in pulmonary arterial hypertension: Focus on preserving right ventricular            function. Physiol Int. 2020;            107(2): 177\u201394.","DOI":"10.1556\/2060.2020.00021"},{"key":"12","unstructured":"12. Jones,              PL,                Cowan,              KN,                Rabinovitch,                M.            Tenascin-C, proliferation and subendothelial fibronectin in progressive            pulmonary vascular disease. Am J Pathol.            1997; 150(4):            1349\u201360."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Dahal,              BK,                Cornitescu,                T,                Tretyn,              A,                Pullamsetti,                SS,                Kosanovic,                D,                Dumitrascu,                R, et al.          Role of epidermal growth factor inhibition in experimental pulmonary            hypertension. Am J Respir Crit Care Med.            2010; 181(2):            158\u201367.","DOI":"10.1164\/rccm.200811-1682OC"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Benisty,                JI,                McLaughlin,                VV,                Landzberg,                MJ,                Rich,              JD,                Newburger,                JW,                Rich,              S, et al.          Elevated basic fibroblast growth factor levels in patients with pulmonary            arterial hypertension. Chest. 2004;            126(4): 1255\u201361.","DOI":"10.1378\/chest.126.4.1255"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zheng,              Y,                Ma,              H,                Hu,              E,                Huang,              Z,                Cheng,              X,                Xiong,              C. Inhibition            of FGFR signaling with PD173074 ameliorates monocrotaline-induced pulmonary arterial            hypertension and rescues BMPR-II expression. J Cardiovasc            Pharmacol. 2015; 66(5):            504\u201314.","DOI":"10.1097\/FJC.0000000000000302"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shi,              L,                Kojonazarov,                B,                Elgheznawy,                A,                Popp,              R,                Dahal,              BK,                B\u00f6hm,              M, et al.          miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular            failure: a novel therapeutic approach. Cardiovasc Res.            2016; 111(3):            184\u201393.","DOI":"10.1093\/cvr\/cvw065"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sun,              M,                Ramchandran,                R,                Chen,              J,                Yang,              Q,                Raj,              JU. Smooth            muscle insulin-like growth factor-1 mediates hypoxia-induced pulmonary hypertension in            neonatal mice. Am J Respir Cell Mol Biol.            2016; 55(6):            779\u201391.","DOI":"10.1165\/rcmb.2015-0388OC"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Connolly,                M,                Garfield,                BE,                Crosby,              A,                Morrell,              NW,                Wort,              SJ,                Kemp,              PR. miR-322-5p            targets IGF-1 and is suppressed in the heart of rats with pulmonary            hypertension. FEBS Open Bio. 2018;            8(3): 339\u201348.","DOI":"10.1002\/2211-5463.12369"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Schermuly,                RT,                Dony,              E,                Ghofrani,                HA,                Pullamsetti,                S,                Savai,              R,                Roth,              M, et al.          Reversal of experimental pulmonary hypertension by PDGF            inhibition. J Clin Invest. 2005;            115(10): 2811\u201321.","DOI":"10.1172\/JCI24838"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Perros,              F,                Montani,              D,                Dorfm\u00fcller,                P,                Durand-Gasselin,                I,                Tcherakian,                C,                Le Pavec,              J, et al.          Platelet-derived growth factor expression and function in idiopathic            pulmonary arterial hypertension. Am J Respir Crit Care            Med. 2008; 178(1):            81\u20138.","DOI":"10.1164\/rccm.200707-1037OC"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Selimovic,                N,                Bergh,              CH,                Andersson,                B,                Sakiniene,                E,                Carlsten,              H,                Rundqvist,                B. Growth            factors and interleukin-6 across the lung circulation in pulmonary            hypertension. Eur Respir J. 2009;            34(3): 662\u20138.","DOI":"10.1183\/09031936.00174908"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Voelkel,                NF,                Gomez-Arroyo,                J. The role            of vascular endothelial growth factor in pulmonary arterial hypertension. The            angiogenesis paradox. Am J Respir Cell Mol Biol.            2014; 51(4):            474\u201384.","DOI":"10.1165\/rcmb.2014-0045TR"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cao,              Y. Multifarious            functions of PDGFs and PDGFRs in tumor growth and metastasis.            Trends Mol Med. 2013;          19(8): 460\u201373.","DOI":"10.1016\/j.molmed.2013.05.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Noskovi\u010dov\u00e1,                N,                Pet\u0159ek,              M,                Eickelberg,                O,                Heinzelmann,                K.            Platelet-derived growth factor signaling in the lung. From lung            development and disease to clinical studies. Am J Respir Cell            Mol Biol. 2015; 52(3):            263\u201384.","DOI":"10.1165\/rcmb.2014-0294TR"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Solinc,              J,                Ribot,              J,                Soubrier,              F,                Pavoine,              C,                Dierick,              F,                Nadaud,              S. The            platelet-derived growth factor pathway in pulmonary arterial hypertension: still an            interesting target?          Life (Basel). 2022; 12(5):            658.","DOI":"10.3390\/life12050658"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ma,                CN,                Shi,              SR,                Zhang,              XY,                Xin,              GS,                Zou,              X,                Li,              WL, et al.          Targeting PDGF\/PDGFR signaling pathway by microRNA, lncRNA, and circRNA for            therapy of vascular diseases: a narrow review.            Biomolecules. 2024;          14(11): 1446.","DOI":"10.3390\/biom14111446"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ten                Freyhaus, H,                Berghausen,                EM,                Janssen,              W,                Leuchs,              M,                Zierden,              M,                Murmann,              K, et al.          Genetic ablation of PDGF-dependent signaling pathways abolishes vascular            remodeling and experimental pulmonary hypertension. Arterioscler            Thromb Vasc Biol. 2015; 35(5):            1236\u201345.","DOI":"10.1161\/ATVBAHA.114.304864"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yamamura,                A,                Nayeem,              MJ,                Al Mamun,              A,                Takahashi,                R,                Hayashi,              H,                Sato,              M.            Platelet-derived growth factor up-regulates Ca<sup>2+<\/sup>-sensing            receptors in idiopathic pulmonary arterial hypertension. FASEB            J. 2019; 33(6):            7363\u201374.","DOI":"10.1096\/fj.201802620R"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hofer,              AM,                Brown,              EM.            Extracellular calcium sensing and signalling. Nat            Rev Mol Cell Biol. 2003; 4(7):            530\u20138.","DOI":"10.1038\/nrm1154"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Magno,              AL,                Ward,              BK,                Ratajczak,                T. The            calcium-sensing receptor: a molecular perspective. Endocr            Rev. 2011; 32(1):            3\u201330.","DOI":"10.1210\/er.2009-0043"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yamamura,                A.            Pathological function of Ca<sup>2+<\/sup>-sensing receptor in pulmonary            arterial hypertension. J Smooth Muscle Res.            2014; 50: 8\u201317.","DOI":"10.1540\/jsmr.50.8"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hendy,              GN,                Canaff,              L.            Calcium-sensing receptor gene: regulation of expression.            Front Physiol. 2016; 7:            394.","DOI":"10.3389\/fphys.2016.00394"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yamamura,                A,                Guo,              Q,                Yamamura,              H,                Zimnicka,                AM,                Pohl,              NM,                Smith,              KA, et al.          Enhanced Ca<sup>2+<\/sup>-sensing receptor function in idiopathic pulmonary            arterial hypertension. Circ Res. 2012;            111(4): 469\u201381.","DOI":"10.1161\/CIRCRESAHA.112.266361"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yamamura,                A,                Yamamura,              H,                Guo,              Q,                Zimnicka,                AM,                Wan,              J,                Ko,              EA, et al.          Dihydropyridine Ca<sup>2+<\/sup> channel blockers increase cytosolic              [Ca<sup>2+<\/sup>] by activating Ca<sup>2+<\/sup>-sensing receptors in pulmonary            arterial smooth muscle cells. Circ Res.            2013; 112(4):            640\u201350.","DOI":"10.1161\/CIRCRESAHA.113.300897"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Guo,              Q,                Huang,              JA,                Yamamura,              A,                Yamamura,              H,                Zimnicka,                AM,                Fernandez,                R, et al.          Inhibition of the Ca<sup>2+<\/sup>-sensing receptor rescues pulmonary            hypertension in rats and mice. Hypertens Res.            2014; 37(2):            116\u201324.","DOI":"10.1038\/hr.2013.129"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Tang,              H,                Yamamura,              A,                Yamamura,              H,                Song,              S,                Fraidenburg,                DR,                Chen,              J, et al.          Pathogenic role of calcium-sensing receptors in the development and            progression of pulmonary hypertension. Am J Physiol Lung Cell            Mol Physiol. 2016; 310(9):            L846\u201359.","DOI":"10.1152\/ajplung.00050.2016"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kawade,              A,                Yamamura,              A,                Fujiwara,              M,                Kobayashi,                S,                Mori,              S,                Horii,              C, et al.          Comparative analysis of age in monocrotaline-induced pulmonary hypertensive            rats. J Pharmacol Sci. 2021;            147(1): 81\u20135.","DOI":"10.1016\/j.jphs.2021.05.012"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Miyaki,              R,                Yamamura,              A,                Kawade,              A,                Fujiwara,              M,                Kondo,              R,                Suzuki,              Y, et al.          SKF96365 activates calcium-sensing receptors in pulmonary arterial smooth            muscle cells. Biochem Biophys Res Commun.            2022; 607: 44\u20138.","DOI":"10.1016\/j.bbrc.2022.03.121"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Bromberg,                JF.            Activation of STAT proteins and growth control.            BioEssays. 2001; 23(2):            161\u20139.","DOI":"10.1002\/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Roger,              I,                Milara,              J,                Montero,              P,                Cortijo,              J. The role of            JAK\/STAT molecular pathway in vascular remodeling associated with pulmonary            hypertension. Int J Mol Sci. 2021;            22(9): 4980.","DOI":"10.3390\/ijms22094980"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Merklinger,                SL,                Jones,              PL,                Martinez,                EC,                Rabinovitch,                M. Epidermal            growth factor receptor blockade mediates smooth muscle cell apoptosis and improves            survival in rats with pulmonary hypertension.            Circulation. 2005; 112(3):            423\u201331.","DOI":"10.1161\/CIRCULATIONAHA.105.540542"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Tu,                L,                De Man,              FS,                Girerd,              B,                Huertas,              A,                Chaumais,                MC,                Lecerf,              F, et al.          A critical role for p130<sup>Cas<\/sup> in the progression of pulmonary            hypertension in humans and rodents. Am J Respir Crit Care            Med. 2012; 186(7):            666\u201376.","DOI":"10.1164\/rccm.201202-0309OC"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Ambade,              AS,                Jung,              B,                Lee,              D,                Doods,              H,                Wu,              D.            Triple-tyrosine kinase inhibition attenuates pulmonary arterial            hypertension and neointimal formation. Transl Res.            2019; 203: 15\u201330.","DOI":"10.1016\/j.trsl.2018.07.010"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Ciuclan,              L,                Hussey,              MJ,                Burton,              V,                Good,              R,                Duggan,              N,                Beach,              S, et al.          Imatinib attenuates hypoxia-induced pulmonary arterial hypertension            pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan            hydroxylase 1 expression. Am J Respir Crit Care Med.            2013; 187(1):            78\u201389.","DOI":"10.1164\/rccm.201206-1028OC"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Pankey,              EA,                Thammasiboon,                S,                Lasker,              GF,                Baber,              S,                Lasky,              JA,                Kadowitz,                PJ. Imatinib            attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in            pulmonary and systemic vascular beds in the rat. Am J Physiol            Heart Circ Physiol. 2013; 305(9):            H1288\u201396.","DOI":"10.1152\/ajpheart.00329.2013"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Hoeper,              MM,                Barst,              RJ,                Bourge,              RC,                Feldman,              J,                Frost,              AE,                Gali\u00e9,              N, et al.          Imatinib mesylate as add-on therapy for pulmonary arterial hypertension:            results of the randomized IMPRES study. Circulation.            2013; 127(10):            1128\u201338.","DOI":"10.1161\/CIRCULATIONAHA.112.000765"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Lythgoe,                MP,                Rhodes,              CJ,                Ghataorhe,                P,                Attard,              M,                Wharton,              J,                Wilkins,              MR. Why drugs            fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in            the future. Pharmacol Ther. 2016;            164: 195\u2013203.","DOI":"10.1016\/j.pharmthera.2016.04.012"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Medarametla,                V,                Festin,              S,                Sugarragchaa,                C,                Eng,              A,                Naqwi,              A,                Wiedmann,              T, et al.          PK10453, a nonselective platelet-derived growth factor receptor inhibitor,            prevents the progression of pulmonary arterial hypertension.            Pulm Circ. 2014; 4(1):            82\u2013102.","DOI":"10.1086\/674881"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Stohs,              SJ,                Miller,              H,                Kaats,              GR. A review of            the efficacy and safety of banaba (<i>Lagerstroemia speciosa<\/i> L.) and            corosolic acid. Phytother Res. 2012;            26(3): 317\u201324.","DOI":"10.1002\/ptr.3664"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Zhao,              J,                Zhou,              H,                An,              Y,                Shen,              K,                Yu,              L. Biological            effects of corosolic acid as an anti-inflammatory, anti-metabolic syndrome and            anti-neoplasic natural compound. Oncol Lett.            2021; 21(2): 84.","DOI":"10.3892\/ol.2020.12345"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51. Qian,              XP,                Zhang,              XH,                Sun,              LN,                Xing,              WF,                Wang,              Y,                Sun,              SY, et al.          Corosolic acid and its structural analogs: a systematic review of their            biological activities and underlying mechanism of action.            Phytomedicine. 2021; 91:            153696.","DOI":"10.1016\/j.phymed.2021.153696"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Kawade,              A,                Yamamura,              A,                Kondo,              R,                Suzuki,              Y,                Yamamura,              H. Corosolic            acid ameliorates vascular remodeling in pulmonary arterial hypertension via the            downregulation of STAT3 signaling. J Pharmacol Sci.            2023; 151(2):            119\u201327.","DOI":"10.1016\/j.jphs.2022.12.007"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Yamamura,                A,                Fujiwara,              M,                Kawade,              A,                Amano,              T,                Hossain,              A,                Nayeem,              MJ, et al.          Corosolic acid attenuates platelet-derived growth factor signaling in            macrophages and smooth muscle cells of pulmonary arterial hypertension.            Eur J Pharmacol. 2024; 973:            176564.","DOI":"10.1016\/j.ejphar.2024.176564"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Sommer,              N,                Ghofrani,                HA,                Pak,              O,                Bonnet,              S,                Provencher,                S,                Sitbon,              O, et al.          Current and future treatments of pulmonary arterial            hypertension. Br J Pharmacol. 2021;            178(1): 6\u201330.","DOI":"10.1111\/bph.15016"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Humbert,              M,                McLaughlin,                V,                Gibbs,              JSR,                Gomberg-Maitland,                M,                Hoeper,              MM,                Preston,              IR, et al.          PULSAR Trial Investigators          Sotatercept for the treatment of pulmonary arterial            hypertension. N Engl J Med. 2021;            384(13): 1204\u201315.","DOI":"10.1056\/NEJMoa2024277"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Andre,              P,                Joshi,              SR,                Briscoe,              SD,                Alexander,                MJ,                Li,              G,                Kumar,              R. Therapeutic            approaches for treating pulmonary arterial hypertension by correcting imbalanced TGF-\u03b2            superfamily signaling. Front Med (Lausanne).            2022; 8: 814222.","DOI":"10.3389\/fmed.2021.814222"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Gallardo-Vara,                E,                Ntokou,              A,                Dave,              JM,                Jovin,              DG,                Saddouk,              FZ,                Greif,              DM. Vascular            pathobiology of pulmonary hypertension. J Heart Lung            Transplant. 2023; 42(5):            544\u201352.","DOI":"10.1016\/j.healun.2022.12.012"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Qi,                YX,                Jiang,              J,                Jiang,              XH,                Wang,              XD,                Ji,              SY,                Han,              Y, et al.          PDGF-BB and TGF-\u03b21 on cross-talk between endothelial and smooth muscle            cells in vascular remodeling induced by low shear stress. Proc            Natl Acad Sci USA. 2011; 108(5):            1908\u201313.","DOI":"10.1073\/pnas.1019219108"}],"container-title":["Journal of Smooth Muscle Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsmr\/61\/0\/61_0564\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T04:44:01Z","timestamp":1757133841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsmr\/61\/0\/61_0564\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":58,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1540\/jsmr.61.82","relation":{},"ISSN":["0916-8737","1884-8796"],"issn-type":[{"value":"0916-8737","type":"print"},{"value":"1884-8796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"0564"}}